OLT-202

N/A

Report date: 2023/02/18 19:34:50

Base Information

Drug NameOLT-202
Drug Alias NameOLT-202
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentral Manchester University Hospitals Nhs Foundation TrustThe University Of Manchester
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of ManchesterCentral Manchester University Hospitals Nhs Foundation Trust
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A